You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gastro-esophageal junction

Showing 1 - 25 of 3,978
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

Minimally Invasive Surgery of the Gastro-esophageal Junction

Recruiting
  • Achalasia
  • +4 more
    • Ottawa, Ontario, Canada
      Ottawa Hospital Research Institute
    Mar 21, 2022

    Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Trial in Guangzhou (zolbetuximab)

    Completed
    • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
    • Guangzhou, China
      Site CN86001
    Jan 11, 2022

    Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

    Recruiting
    • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
    • Beijing, China
      Chinese Academy of Medical Sciences
    Mar 9, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • CS1001 monoclonal antibody
    • +3 more
    • Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2022

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85

    Active, not recruiting
    • Gastro-Esophageal Junction Adenocarcinoma
    • Gastric Cancer
    • Nab-paclitaxel 150 mg/m^2
    • +3 more
    • Chicago, Illinois
    • +7 more
    Feb 16, 2022

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

    Active, not recruiting
    • Adenocarcinoma of the Esophagus
    • +5 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jul 25, 2022

    Stretta Device Trial in Leuven (Stretta, Sham)

    Recruiting
    • Stretta Device
    • Stretta
    • Sham
    • Leuven, Belgium
      Annelies Geeraerts
    Oct 26, 2021

    Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

    Not yet recruiting
    • Gastric Cancer Stage IV
    • Seoul, Korea, Republic of
      Severance Hospital
    Aug 29, 2021

    Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer Trial in Kashiwa (Zolbetuximab)

    Completed
    • Gastric Cancer
    • Gastro-esophageal Junction (GEJ) Cancer
    • Kashiwa, Chiba, Japan
      Site JP00001
    Mar 3, 2021

    Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

    Completed
    • Squamous Cell Carcinoma
    • +3 more
    • Amsterdam, Netherlands
      Academic Medical Center
    Apr 19, 2021

    Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Jacksonville, Florida
    • +16 more
    Aug 17, 2023

    Gastric Cancer, Gastro-oesophageal Junction Cancer, Immunotherapy Trial in Shanghai (Anlotinib Plus Toripalimab)

    Recruiting
    • Gastric Cancer
    • +4 more
    • Anlotinib Plus Toripalimab
    • Shanghai, China
      Department of Medical Oncology, Shanghai Changzheng Hospital
    Dec 28, 2020

    Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer Trial in Seoul (autologous activated T

    Recruiting
    • Relapsed or Advanced Gastric Adenocarcinoma
    • Gastro-esophageal Junction Cancer
    • autologous activated T lymphocyte
    • Seoul, Korea, Republic of
      Gangnam Severacen Hospital
    Sep 15, 2021

    Stomach Cancer, Gastro Esophageal Junction Cancer Trial in Amsterdam, Eindhoven (Atezolizumab, Capecitabine, Oxaliplatin)

    Recruiting
    • Stomach Cancer
    • Gastro Esophageal Junction Cancer
    • Amsterdam, Netherlands
    • +1 more
    Apr 19, 2021

    Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2

    Recruiting
    • Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment
    • Duarte, California
    • +12 more
    Jul 6, 2022

    Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

    Active, not recruiting
    • Clinical Stage III Gastric Cancer AJCC v8
    • +7 more
    • Duarte, California
    • +30 more
    Jan 7, 2023

    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

    Terminated
    Has Results
    • Adenocarcinoma of the Esophagus
    • +13 more
    • oblimersen sodium
    • +2 more
    • Bronx, New York
      Montefiore Medical Center
    Jan 29, 2021

    Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • (no location specified)
    Jun 12, 2023

    Clinical & Pathological Studies of Upper Gastrointestinal

    Recruiting
    • Stomach Cancer
    • +4 more
    • Blood draw
    • Tissue tumor biopsy
    • Stanford, California
      Stanford University School of Medicine
    Jul 29, 2021

    Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • TRK-950
    • +2 more
    • Chuo Ku, Japan
      Osaka International Cancer Institute
    Sep 14, 2023

    Gastroesophageal Reflux Disease With Ulceration Trial in Marseille (endoscopic mucosal resection, sham)

    Recruiting
    • Gastroesophageal Reflux Disease With Ulceration
    • endoscopic mucosal resection
    • sham
    • Marseille, France
      AP-HM
    Feb 15, 2023

    Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

    Completed
    • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
    • +5 more
    • S-1 de-escalation
    • Chemotherapy by Investigator's choice
    • Heidelberg, Baden-Württemberg, Germany
      NCT-Med. Onkologie
    Mar 25, 2021